iPSC Culture Process for Clearing Exogenous Vector Residuals
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing induced pluripotent stem cells (iPSCs) using non-integrating viral or non-viral reprogramming systems result in residual vector copies that are challenging to clear, which is a barrier for clinical applications.
Innovation Solution
A modified process involving low-density seeding, optional repetition of seeding, and culturing at elevated temperatures, followed by selective passaging, is employed to produce iPSCs essentially free of exogenous vector residuals.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If non-integrating viral or non-viral reprogramming systems are used to produce iPSCs, then reprogramming efficiency is improved, but residual vector copies remain in the iPSCs
Solution Approach 1:
The patent extracts and removes residual vector copies from iPSCs through multiple passaging steps. The method involves separating iPSCs into single cells, seeding at low density to allow individual colony formation, and selectively passaging to eliminate cells containing residual vectors while maintaining pure clonal populations.
Solution Approach 2:
The patent applies preliminary actions by performing multiple rounds of low-density seeding and passaging before clinical application. These preliminary culture steps pre-clear residual vectors from the iPSC population, ensuring safety before the cells are used for therapeutic purposes.
2Manufacturing precision
If multiple passaging procedures are performed to clear vector residuals, then purity of iPSCs is improved, but time required for production increases
Solution Approach 1:
The patent changes critical culture parameters including seeding density (reducing to low density), temperature (elevated to 37-39°C), and passaging frequency. These parameter modifications optimize the balance between clearing residual vectors and maintaining productive cell expansion, achieving purity in a reasonable time frame.
Solution Approach 2:
The patent implements dynamic culture conditions by adjusting seeding density and passaging timing based on colony formation rates and vector clearance progress. This dynamic approach allows optimization of the purification process at each stage, reducing overall production time while maintaining high purity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method effectively clears exogenous vector residuals, producing iPSCs that are suitable for clinical use by ensuring they are essentially free of such contaminants.
Implementation Method 1
The culture medium of step b) is a fully defined medium. In some embodiments, the culture medium is Essential 8 medium. In some embodiments, step b), each time performed, independently comprises culturing the iPSCs in the culture medium supplemented with a ROCK inhibitor.
Implementation Method 2
the Sendai viral vector comprises one or more temperature-sensitive mutations. In some embodiments, step d) comprises culturing the iPSCs at the elevated temperature for about 5-8 days.
Data Source
AI summary
Provided herein are methods of producing and manufacturing iPSCs, such as iPSCs essentially free of exogeneous viral residuals, and RPE cells. Such methods may comprise cell seeding at low density (e.g., single-cell passaging) and/or culturing at elevated temperature.